Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS8179 for Brain Swelling After Large Hemispheric Infarction
NCT05690711Phase 2Completed
- Sponsor
- Beijing Suncadia Pharmaceuticals Co., Ltd.
- Start
- Apr 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS8179 in cerebral edema, sponsored by Beijing Suncadia Pharmaceuticals Co., Ltd.. Started Apr 2023; status: completed.
02
Drugs
HRS8179
03
Conditions
cerebral edema
Beyond the preview
Go deeper on NCT05690711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05690711.